Watson Gets Approval For Emergency Contraceptive

Stock quotes in this article: WPI  

CORONA, Calif. (AP) — Watson Pharmaceuticals Inc. said Friday it received Food and Drug Administration approval for its over-the-counter version of the emergency contraceptive Plan B, which is made by Barr Pharmaceuticals unit Duramed.

The drug is already available over the counter.

Watson will call its version Next Choice. It is meant to be taken within 72 hours of unprotected intercourse to reduce the chance of pregnancy.

Watson said U.S. sales of Plan B reached $135 million during the 12 months ended June 30, 2009.

Shares of Watson rose 11 cents to $35.46 in after-hours trading after rising 33 cents to close at $35.35 during the regular trading session.

  • Loading Comments...
  •  

SHARE:

  • email
  • print
  • comment
  • digg
  • delicious
  • linkedin
Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Recent Comments





Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
10,441.12 1,109.18 2,206.91 35.96
Oil *
73.55
DOWN
10.88
UP
1.25
UP
5.86
DOWN
0.07
10 Yr
3.60%
SPDR Gold
111.59
-0.10%
+0.11%
+0.27%
-0.19%
Data delayed 20 minutes

More From TheStreet

Latest Headlines

Brokerage Partners

TheStreet Premium Services

All Services